Heeringa Saskia F, Vlangos Christopher N, Chernin Gil, Hinkes Bernward, Gbadegesin Rasheed, Liu Jinhong, Hoskins Bethan E, Ozaltin Fatih, Hildebrandt Friedhelm
Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109-5646, USA.
Nephrol Dial Transplant. 2008 Nov;23(11):3527-33. doi: 10.1093/ndt/gfn271. Epub 2008 May 23.
Congenital nephrotic syndrome (CNS) is de- fined as nephrotic syndrome that manifests at birth or within the first 3 months of life. Most patients develop end-stage renal disease (ESRD) within 2 to 3 years of life. CNS of the Finnish-type (CNF) features a rather specific renal histology and is caused by recessive mutations in the NPHS1 gene encoding nephrin, a major structural protein of the glomerular slit-diaphragm. So far, more than 80 different mutations of NPHS1 causing CNF have been published.
Here, we performed mutation analysis of NPHS1 by exon sequencing in a worldwide cohort of 32 children with CNS from 29 different families.
Sixteen of the 29 families (55%) were found to have two disease-causing alleles in NPHS1. Two additional patients had a single heterozygous mutation in NPHS1. Thirteen of a total of 20 different mutations detected were novel (65%). These were five missense mutations, one nonsense mutation, three deletions, one insertion and three splice-site mutations.
Our data expand the spectrum of known NPHS1 mutations by >15% in a worldwide cohort. Surprisingly, two patients with disease-causing mutations showed a relatively mild phenotype, as one patient had a partial remission with steroid treatment and one patient had normal renal function 1 year after the onset of disease. The increased number of known mutations will facilitate future studies into genotype/phenotype correlations.
先天性肾病综合征(CNS)被定义为在出生时或出生后3个月内出现的肾病综合征。大多数患者在2至3岁时发展为终末期肾病(ESRD)。芬兰型先天性肾病综合征(CNF)具有相当特殊的肾脏组织学特征,由编码nephrin(肾小球裂孔隔膜的主要结构蛋白)的NPHS1基因的隐性突变引起。到目前为止,已发表了80多种导致CNF的NPHS1不同突变。
在此,我们通过外显子测序对来自29个不同家庭的32名患有CNS的儿童的全球队列进行了NPHS1突变分析。
29个家庭中的16个(55%)被发现NPHS1中有两个致病等位基因。另外两名患者在NPHS1中有一个杂合突变。在总共检测到的20种不同突变中,有13种是新的(65%)。这些是5个错义突变、1个无义突变、3个缺失、1个插入和3个剪接位点突变。
我们的数据使全球队列中已知的NPHS1突变谱扩大了15%以上。令人惊讶的是,两名具有致病突变的患者表现出相对较轻的表型,一名患者经类固醇治疗后部分缓解,一名患者在疾病发作1年后肾功能正常。已知突变数量的增加将有助于未来对基因型/表型相关性的研究。